Alpha Tau Medical Ltd.

NASDAQ:DRTS

Biotechnology

Healthcare
$12.01 +0.42%

+$0.04 today

Market cap
$1.11B
Beta
1.20
P/E (TTM)
-15.2
EPS (TTM)
-$0.63
52W Low $2.85High $11.62

Volume 0.64M

Average 0.69M

DRTS Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Alpha Tau Medical Ltd.NASDAQ: DRTS

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin grows, but more slowly than its trailing trend

Q1 FY2026 selling, general & admin of $2.34M rose 9.4% year over year, behind the +13.5% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 22.7% from the prior quarter. Over 3 fiscal years it compounded at -3.1% a year.

Context

  • Selling, general & admin increased in 1 of the last 3 fiscal years.

What to watch

Whether selling, general & admin reaches the consensus estimate from 2 analysts of $0 (-100.0%) for the fiscal year ending Dec 2026, a slowdown from the +29.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.34M-22.7% QoQ
Last fiscal yearDec 2025
$10.22M+29.1% YoY
LTMMar 2026
$10.42M+13.5% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+9.4%-100.0%-109.4 pp
1 year+29.1%-100.0%-129.1 pp
3-year CAGR-3.1%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
10.22M USD
Year-over-year change
+29.1%
4-year CAGR
+44.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How DRTS compares with its peers on the latest reported figures

  • DRTS's LTM Mar 2026 selling, general & admin of $10.42M is the lowest of the 3 companies compared; the peer median is $20.99M.
  • Its year-over-year change of +13.5% is the highest of 3, against a peer median of +7.1%.
  • Over three fiscal years its annual growth of -3.1% compares with a peer median of +31.9%.
DRTS Competitors Peer median
Selling, General & Admin for DRTS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CATXPerspective Therapeutics, Inc.LTM Mar 2026$29.38M +2.8%+28.6%4753.4%
AKTSAktis Oncology, Inc.FY2025$12.6M +11.4%+35.1%193.9%
DRTSAlpha Tau Medical Ltd.LTM Mar 2026$10.42M +13.5%-3.1%—
Peer median (excluding DRTS) $20.99M+7.1%+31.9%2473.7%

Competitors are the stored peer set for DRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue776K979K1.07M1.1M1.23M
Gross Profit(776K)(979K)(1.07M)(1.1M)(1.23M)
Gross Margin—————
Research & Development11.45M20.89M26.42M27.02M30.83M
Selling, General & Admin2.34M11.25M9.26M7.92M10.22M
Operating Expenses13.79M32.14M34.61M34.94M41.06M
Depreciation & Amortization776K979K1.07M1.1M1.23M
EBITDA(13.22M)(32.74M)(28.03M)(30.3M)(41.06M)
EBITDA Margin—————
Operating Income(13.79M)(32.14M)35.68M(36.04M)(42.29M)
Operating Margin—————
Interest Income211K1.79M4.76M4.28M3.84M
Interest Expense13.27M1.77M39K344K419K
Other Income / Expenses(13.47M)(1.61M)6.54M4.3M(218K)
Income Before Tax(27.26M)(33.74M)(29.14M)(31.74M)(42.51M)
Pre-Tax Margin—————
Income Tax Expense7K20K16K6K121K
Net Income(27.27M)(33.76M)(29.16M)(31.75M)(42.63M)
Net Margin—————
EPS (Basic)(0.67)(0.53)(0.42)(0.45)(0.53)
EPS (Diluted)(0.67)(0.53)(0.42)(0.45)(0.53)
Weighted Avg Shares40.53M63.53M69.38M69.93M80.58M
Weighted Avg Shares (Diluted)40.53M63.53M69.38M69.93M80.58M

Alpha Tau Medical Ltd.

NASDAQ:DRTS

Intrinsic Alpha fair value

Locked

Current Price

$12.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.